• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ABBOTT PRISM HIV O PLUS; HIV-1 AND HIV-2 ANTIBODIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ABBOTT PRISM HIV O PLUS; HIV-1 AND HIV-2 ANTIBODIES Back to Search Results
Catalog Number 03D34-48
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/08/2019
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There was no additional patient information provided by the customer.This report is being filed on an international product, prism hiv o plus, list 3d34, that has a similar product distributed in the us, list 3l68.
 
Event Description
The customer reported (b)(6) prism hiv results on 44 donor samples.The customer provided data for 44 repeat (b)(6) donors, and they were confirmed (b)(6) on alinity.There was no reported impact to donor management.
 
Manufacturer Narrative
Review of complaint activity determined there was normal complaint activity for the prism hiv o plus reagent, lot 90502li00.Tracking and trending report review determined there are no related adverse or non- statistical trends.The performance of the likely cause lot was investigated, and no issues were identified.A retained reagent kit of lot 90502li00 was calibrated, and the calibration met instrument specifications; all control values met control specifications and were in range.A negative human population panel (106 samples) were tested and no false reactive results were obtained.Labeling was reviewed and sufficiently addresses the customer's issue.Based on the investigation, no systemic issue or deficiency was identified for the prism hiv o plus reagent, lot 90502li00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABBOTT PRISM HIV O PLUS
Type of Device
HIV-1 AND HIV-2 ANTIBODIES
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
MDR Report Key8653845
MDR Text Key209393654
Report Number1415939-2019-00034
Device Sequence Number1
Product Code MZF
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 07/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/24/2019
Device Catalogue Number03D34-48
Device Lot Number90502LI00
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 05/08/2019
Initial Date FDA Received05/30/2019
Supplement Dates Manufacturer Received07/04/2019
Supplement Dates FDA Received07/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PRISM, LIST# 06A36-04, SERIAL # (B)(4); PRISM, LIST# 06A36-04, SERIAL # (B)(4)
-
-